Klassen Preston 4
4 · Metacrine, Inc. · Filed Apr 20, 2022
Insider Transaction Report
Form 4
Metacrine, Inc.MTCR
Klassen Preston
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2022-04-19$0.50/sh−43,575$21,879→ 923,683 total - Sale
Common Stock
2022-04-19$0.51/sh−1,173$593→ 922,510 total
Footnotes (1)
- [F1]Sale of shares to cover tax withholding obligations associated with the vesting of the performance-based restricted stock unit award granted to the Reporting Person on June 1, 2021 (as modified on March 23, 2022).